XORTX THERAPEUTICS INC (XRTX) Stock Cash Flow
NASDAQ:XRTX - Nasdaq - CA98420Q3061 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -736.66K | -2.16M | -7.00M | -1.22M | -948.53K | |||
| Depreciation Amortization | 115.49K | 139.69K | 58.15K | 12.81K | 15.26K | |||
| Change In Working Capital | -23.22K | -1.03M | 1.47M | -986.71K | 270.49K | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | -3.45M | -3.53M | -2.78M | -2.19M | 129.60K | |||
| OPERATING CASH FLOW | -4.09M | -6.58M | -8.96M | -4.34M | -543.95K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -44.68K | -46.36K | -45.70K | -28.53K | -10.72K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -44.68K | -46.36K | -45.70K | -28.53K | -10.72K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -64.04K | -66.09K | -20.41K | N/A | N/A | |||
| Stock Issued/Repurchased | 2.02M | 300.00 | 5.00M | 18.14M | 672.09K | |||
| Other Financing Activity | -592.86K | -295.25K | -269.56K | -613.57K | -33.30K | |||
| FINANCING CASH FLOW | 1.36M | -361.04K | 4.71M | 17.53M | 638.79K | |||
| Exchange Rate Effect | 6.29K | 4.04K | -136.15K | 233.46K | N/A | |||
| CHANGE IN CASH | -2.77M | -6.99M | -4.44M | 13.39M | 84.13K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.09M | -6.58M | -8.96M | -4.34M | -543.95K | |||
| Capital Expenditure | -44.68K | -46.36K | -45.70K | -28.53K | -10.72K | |||
| FREE CASH FLOW | -4.13M | -6.63M | -9.01M | -4.37M | -554.66K | |||
All data in USD